Patent · US Active

6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders

US8912203B2 · kind B2 · utility

1Cited by
0References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2011
Grant dateDec 16, 2014
Priority date—
Expiry dateSep 4, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.